News

On November 3rd and 4th the Moving Up team ran their second Employability Weekend in London Stratford.

An overview of the recent Adult NorthStar Network meeting in London

Myonexus Therapeutics has initiated the first-ever gene therapy (MYO-101) trial for people with limb girdle muscular dystrophy type 2E (LGMD 2E).

An international team of experts have published consensus-based care recommendations to help clinicians deliver high standards of care to adults with myotonic dystrophy 1.

People with neuromuscular conditions and health professionals highlighted priorities for improving access to care and treatments at the Northern Ireland All Party Group meeting.

Round-Up Powerchair Football Premiership

Pharmaceutical company, Biogen, has released a statement to the SMA community about the closure of its Spinraza Expanded Access to Programme for new patients with SMA Type 1.

Yesterday, the Chancellor of the Exchequer delivered the Government’s Budget in a statement to the House of Commons.

We have three overseas challenges in 2019 that you can take on to raise money for Muscular Dystrophy UK.

Dr Sally Whittet has cycled the 220 miles from Old Trafford to Stamford Bridge in memory of her godson, Jonathan.